• HOME
  • DCVAX ® TECHNOLOGY
    • About DCVax®
    • Dendritic Cell Immunotherapy
    • Patient Stories & Physician Comments
  • PRODUCT CANDIDATES
    • DCVax® – L
    • DCVax® – Direct
    • DCVax® – Prostate
  • CLINICAL TRIALS
    • DCVax® – L Phase III for GBM Brain Cancer
    • DCVax® – Direct Phase I/II for All Types of Inoperable Solid Tumor Cancers
  • INVESTORS & MEDIA
    • Press Releases
    • SEC Filings
    • Webcasts
    • Board Committee Charters
    • Code of Conduct
    • Notice of Proposed Settlement
    • Related-Party Transaction Policy
    • Corporate Governance Guidelines
  • ABOUT US
    • Overview
    • Company Management
    • Publications
    • Related Links
    • Contact Us
      • General Inquiries
      • Patient Inquiries

Webcasts

25
JAN
2015

NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum

NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum
January 26, 2015. 10:30AM – 10:50AM EST. Washington, D.C.

12
JAN
2015

NW Bio To Present At Biotech Showcase 2015 Conference

NW Bio to Present at Biotech Showcase 2015 in San Francisco
San Francisco, CA

10
DEC
2014

NW Bio CEO’s Presentation At Oppenheimer’s 25th Annual Healthcare Conference in New York

NW Bio CEO’s Presentation At Oppenheimer’s 25th Annual Healthcare Conference in New York
New York, NY

16
SEP
2014

NW Bio CEO To Present At SMi’s 3rd Annual Cancer Vaccines Conference In London

NW Bio CEO To Present At SMi’s 3rd Annual Cancer Vaccines Conference In London
London, UK

08
SEP
2014

NW Bio To Present Updates At Rodman Renshaw 16th Annual Global Investments Conference

NW Bio To Present Updates At Rodman Renshaw 16th Annual Global Investments Conference
NewYork

04
JUN
2014

NW Bio To Present At Jefferies 2014 Global Healthcare Conference

NW Bio To Present At Jefferies 2014 Global Healthcare Conference
NewYork

27
MAR
2014

Northwest Biotherapeutics to Present at the 4th Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference

Northwest Biotherapeutics to Present at the 4th Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference 
NewYork

10
FEB
2014

2014 BIO CEO & Investor Conference

2014 BIO CEO & Investor Conference 
NewYork

13
JAN
2014

Northwest Biotherapeutics at Biotech Showcase 2014

Northwest Biotherapeutics at Biotech Showcase 2014 
SanFrancisco

123
Follow us On: 
  • DCVAX® TECHNOLOGY
    • About DCVax®
    • Dendritic Cell Immunotherapy
    • Patient Stories & Physician Comments
  • PRODUCT CANDIDATES
    • DCVax® – L
    • DCVax® – Direct
    • DCVax® – Prostate
  • CLINICAL TRIALS
    • Pipeline
    • DCVax® – L Phase III
    • DCVax® – Direct Phase I/II
  • INVESTORS & MEDIA
    • Contacts
    • SEC Filings
    • Stock Information
    • Press Releases
    • Webcasts
  • ABOUT US
    • Overview
    • Company Management
    • Publications
    • Related Links
    • Contact Us

© 2017 Northwest Biotherapeutics, Inc.
4800 Montgomery Lane, Suite 800
Bethesda, MD 20814
Phone: 240-497-9024

  • Forward-looking Statement
  • Legal Disclaimer
  • Privacy Policy